Thiol/Disulfide Homeostasis in Bipolar and Unipolar Depression
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objective: Bipolar disorder and unipolar depressive disorder are complex phenotypes. There appear to be phenotypical, mechanistic, and therapeutic differences between bipolar depression (BD) and unipolar depression (UD). There is a need for understanding the underlying biological variation between these clinical entities. The role of oxidative processes underlying bipolar disorder and depression has been demonstrated. Thiol-disulfide homeostasis (TDH) is a recent oxidative stress marker. In this study, we aimed to inspect patients with bipolar depression and unipolar depression in terms of thiol-disulfide balance and to compare them with healthy controls. Methods: Patients admitted to the outpatient clinic of Ankara Numune Training and Research Hospital and diagnosed either as a depressive episode with bipolar disorder (n = 37) or unipolar depression (n = 24) according to DSM-5 criteria, along with healthy controls (HC) (n = 50), were included in the study. Native thiol, total thiol, and disulfide levels were compared across the groups. Results: In comparison to HC, both BD and UD groups had higher disulfide levels, disulfide/native thiol ratio, and disulfide/total thiol ratio. No significant differences between BD and UD were detected in terms of disulfide level, disulfide/ native thiol ratio, and disulfide/total thiol ratio. Conclusion: Increased levels of disulfide, native thiol, and disulfide/total thiol ratios compared to healthy controls in both UD and BD groups may be indicative of the presence of oxidative damage in these two clinical conditions. To clarify the role of oxidative stress in the pathophysiology of depressive disorders and investigate TDH, longitudinal studies in patients with medication-free UD and BD are required.
Abstract
Objective: Bipolar disorder and unipolar depressive disorder are complex phenotypes. There appear to be phenotypical, mechanistic, and therapeutic differences between bipolar depression (BD) and unipolar depression (UD). There is a need for understanding the underlying biological variation between these clinical entities. The role of oxidative processes underlying bipolar disorder and depression has been demonstrated. Thiol-disulfide homeostasis (TDH) is a recent oxidative stress marker. In this study, we aimed to inspect patients with bipolar depression and unipolar depression in terms of thiol-disulfide balance and to compare them with healthy controls. Methods: Patients admitted to the outpatient clinic of Ankara Numune Training and Research Hospital and diagnosed either as a depressive episode with bipolar disorder (n = 37) or unipolar depression (n = 24) according to DSM-5 criteria, along with healthy controls (HC) (n = 50), were included in the study. Native thiol, total thiol, and disulfide levels were compared across the groups. Results: In comparison to HC, both BD and UD groups had higher disulfide levels, disulfide/native thiol ratio, and disulfide/total thiol ratio. No significant differences between BD and UD were detected in terms of disulfide level, disulfide/ native thiol ratio, and disulfide/total thiol ratio. Conclusion: Increased levels of disulfide, native thiol, and disulfide/total thiol ratios compared to healthy controls in both UD and BD groups may be indicative of the presence of oxidative damage in these two clinical conditions. To clarify the role of oxidative stress in the pathophysiology of depressive disorders and investigate TDH, longitudinal studies in patients with medication-free UD and BD are required.
참고문헌 (42)
- Kleinman L, "Costs of bipolar disorder", Pharmacoeconomics, 21, pp.601~622 (2003)
- Papakostas GI, "Quality of life assessments in major depressive disorder : a review of the literature", Gen Hosp Psychiatry, 26, pp.13~17 (2004)
- Drexhage RC, "Immune and neuroimmune alterations in mood disorders and schizophrenia", Int Rev Neurobiol, 101, pp.169~201 (2011)
- Lakhan SE, "Biomarkers in psychiatry : drawbacks and potential for misuse", Int Arch Med, 3, pp.1~ (2010)
- Vaváková M, "Markers of oxidative stress and neuroprogression in depression disorder", Oxid Med Cell Longev, 2015, pp.898393~ (2015)
- Andreazza AC, "Oxidative stress markers in bipolar disorder : a meta-analysis", J Affect Disord, 111, pp.135~144 (2008)
- Maes M, "A review on the oxidative and nitrosative stress(O&NS)pathways in major depression and their possible contribution to the(neuro)degenerative processes in that illness", Prog Neuropsychopharmacol Biol Psychiatry, 35, pp.676~692 (2011)
- Siwek M, "Oxidative stress markers in affective disorders", Pharmacol Rep, 65, pp.1558~1571 (2013)
- Halliwell B, "Oxidative stress and neurodegeneration : where are we now", J Neurochem, 97, pp.1634~1658 (2006)
- Halliwell B, "Free radicals and antioxidants - quo vadis?", Trends Pharmacol Sci, 32, pp.125~130 (2011)
- Halliwell B, "Using isoprostanes as biomarkers of oxidative stress : some rarely considered issues", Antioxid Redox Signal, 13, pp.145~156 (2010)
- Erel O, "A novel and automated assay for thiol", disulphide homeostasis, 2014, pp.47, 326~332
- Kemp M, "Nonequilibrium thermodynamics of thiol", disulfide redox systems : a perspective on redox systems biology, 2008, pp.44, 921~937
- Circu ML, "Reactive oxygen species, cellular redox systems, and apoptosis", Free Radic Biol Med, 48, pp.749~762 (2010)
- Ozyazici S, "A novel oxidative stress mediator in acute appendicitis : thiol", disulphide homeostasis, 2016, pp.2016, 6761050~
- Biswas S, "Redox modifications of protein-thiols : emerging roles in cell signaling", Biochem Pharmacol, 71, pp.551~564 (2006)
- Incecik F, "Dynamic thiol", disulphide homeostasis in children with Duchenne muscular dystrophy, 2019, pp.119, 215~218
- Erzin G, "Thiol", disulphide homeostasis in bipolar disorder, 2018, pp.261, 237~242
- Smeyne M, "Glutathione metabolism and Parkinson’s disease", Free Radic Biol Med, 62, pp.13~25 (2013)
- Steele ML, "Chronic inflammation alters production and release of glutathione and related thiols in human U373 astroglial cells", Cell Mol Neurobiol, 33, pp.19~30 (2013)
- Topcuoglu C, "Thiol", disulfide homeostasis in untreated schizophrenia patients, 2017, pp.251, 212~216
- Ünal K, "Thiol", disulphide homeostasis in schizophrenia patients with positive symptoms, 2018, pp.72, 281~284
- Akdemir A, "Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale", Compr Psychiatry, 42, pp.161~165 (2001)
- Hamilton M, "A rating scale for depression", J Neurol Neurosurg Psychiatry, 23, pp.56~62 (1960)
- Williams JB, "A structured interview guide for the Hamilton Depression Rating Scale", Arch Gen Psychiatry, 45, pp.742~747 (1988)
- Young RC, "A rating scale for mania : reliability, validity and sensitivity", Br J Psychiatry, 133, pp.429~435 (1978)
- Karadağ F, "Reliability and validity of Turkish translation of Young Mania Rating Scale", Turk Psikiyatri Derg, 13, pp.107~114 (2002)
- Asoğlu M, "Thiol", disulphide homeostasis as a new oxidative stress marker in untreated patients with generalized anxiety disorder, 2018, pp.19, 143~149
- Baykan H, "Dynamic thiol", disulphide homeostasis as a novel oxidative stress marker in women with major depressive disorder, 2018, pp.19, 135~142
- Palta P, "Depression and oxidative stress : results from a meta-analysis of observational studies", Psychosom Med, 76, pp.12~19 (2014)
- Black CN, "Is depression associated with increased oxidative stress? A systematic review and meta-analysis", Psychoneuroendocrinology, 51, pp.164~175 (2015)
- Karaaslan Ö, "Evaluation of thiol", disulfide homeostasis in patients with a first episode of major depressive disorder, 2019, pp.6, 1~7
- Stefanescu C, "The relevance of oxidative stress status in first episode and recurrent depression", J Affect Disord, 143, pp.34~38 (2012)
- Halef Okan Dogan, "Thiol Disulfide Homeostasis in Schizophrenic Patients Using Atypical Antipsychotic Drugs", Clinical Psychopharmacology and Neuroscience, 16(1), pp.39~45 (2018), 대한정신약물학회[DOI]
- Shao L, "Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells", Biol Psychiatry, 58, pp.879~884 (2005)
- Al-Chalabi BM, "Potential effect of olanzapine on total antioxidant status and lipid peroxidation in schizophrenic patients", Neuropsychobiology, 59, pp.8~11 (2009)
- Evans DR, "Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment", Prostaglandins Leukot Essent Fatty Acids, 69, pp.393~399 (2003)
- Park SW, "Effects of antipsychotic drugs on BDNF, GSK-3β, and β-catenin expression in rats subjected to immobilization stress", Neurosci Res, 71, pp.335~340 (2011)
- Wei Z, "Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide", J Neurosci Res, 73, pp.364~368 (2003)
- Bilici M, "Antioxidative enzyme activities and lipid peroxidation in major depression : alterations by antidepressant treatments", J Affect Disord, 64, pp.43~51 (2001)
- Kotan VO, "Effects of long-term antidepressant treatment on oxidative status in major depressive disorder : a 24-week follow-up study", Prog Neuropsychopharmacol Biol Psychiatry, 35, pp.1284~1290 (2011)
- Liu T, "A meta-analysis of oxidative stress markers in depression", PLoS One, 10, pp.e0138904~ (2015)